5Iida F,Iida R,Kamijo H. Chronic Japanese schistosomiasis and hepatocellular carcinoma: ten years of follow-up in Yamanashi Prefecture [ J ]. Japan Bull World Health Organ, 1999,77 ( 7 ): 573-581.
6Wahib AA, Masoud AA, Halem AA, et al. Cell mediated immune response in chronic liver diseases: Schistosomal, viral and neop lastic [ J]. J Egypt Soc Parasitol,1998 ,28 :929-939.
7Leoncio L, Kaw Jr MD, Corazon KP, et al. Surgical Pathology of Colorectal Cancer in Filipinos: Implications for Clinical Practice[J]. Am Col Surg,2002,195(2) ,188-195.
8Badawi AF, Michael MS. Risk factors for hepatocellular carcinoma in Egypt: the role of hepatitis-B viral infection and schistosomiasis[ J ]. Anticancer Res, 1999,19 ( 5 C) :4565-4569.
9Cutroneo KR, BorosDL. Rational basis for oligodeoxynucleotides to inhibit collagen synthesis in lung fibroblasts and primary fibroblasts from liver granulomas of Schistosoma mansoni-infected mice [ J ].Cancer Lett,2002,180 ( 2 ): 145-151.
10Takemura Y, Kikuchi S, Inaba Y . Epidemiologic study of the relationship between schistosomiasis due to Schistosoma japonicum and liver cancer/cirrhosis [J]. Am J Trop Med Hyg, 1998,59(4) :551-556.
1Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J]. Int J Cancer, 2010,127 (12) : 2893-2917.
2Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012[J]. Eur J Cancer, 2013, 49(6): 1374-1403.
3Yang SM, Fang DC, Luo YH, et al. Alterations of telomerease activeity and terminal restriction fragment in gastric cancer and its premalignant lesions[J]. J Gastroenterol Hepatol, 2001, 16 (8): 876-882.
